Portfolio company
Epana Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Epana
The company develops precision immune cell therapies and diagnostic atlases using genomics and artificial intelligence for patients with autoimmune diseases.
EpiBiologics
This company develops bispecific antibodies to degrade extracellular proteins for patients with cancer and autoimmune disorders.
Epics Therapeutics
This biotechnology company develops small-molecule RNA epigenetic modulators to treat patients with solid tumours and autoimmune diseases.
Ouro Medicines
This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.
Graph Therapeutics
This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.
Egle Therapeutics
This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.
Ditto Biosciences
The company develops parasite-derived protein therapies for pharmaceutical and biotechnology partners to treat patients with autoimmune diseases using an artificial intelligence platform.
Attovia Therapeutics
The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.